Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

• Status: Completed
• Trial end date: 2016-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Compare the effect of treatment of midodrine and pyridostigmine in neurogenic orthostatic hypotension and investigate the quality of life of treatment of neurogenic orthostatic hypotension.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Bromides; Midodrine; Pyridostigmine Bromide

Criteria

Inclusion Criteria:

• age >=18 patients who complained of dizziness

• Orthostatic hypotension after 3-minute standing (systolic blood pressure drop >=20 or diastolic blood pressure drop >=10

Exclusion Criteria:

• Drug-induced hypotension, if necessary, evaluate patient after discontinuing the causative drug for one month

• Heart failure or Chronic renal failure

• Patients who cannot or do not want to write questionaires.

• Poor drug compliance